Evaluation of Efficacy and Safety of Empagliflozin in Bangladeshi Patients with Type 2 Diabetes Mellitus (EFFISAEM Study)

Evaluation of Efficacy and Safety of Empagliflozin in Bangladeshi Patients with Type 2 Diabetes Mellitus (EFFISAEM Study)

Background: Empagliflozin is a relatively newer glucose-lowering drug (GLD) with many extra-glycemic benefits. To date, no study has evaluated the efficacy and safety of empagliflozin in Bangladeshi patients with type 2 diabetes mellitus (T2DM). Objectives: To assess the efficacy and safety of empag...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohammad Saifuddin, Ajit K. Paul, Sultana M. Shefin, Md. Jahangir Alam, Shahjada Selim, Sunjida Islam, Tanjina Hossain, Sadiqa Tuqan, Nusrat Sultana, Marufa Mustari, Ramen C. Basak, Kazi A. Aftab, Indrajit Prasad, Mohammad R. Uddin, Shoma Sharker, Md. Abu Jar Gaffar, Mohammad M. Rahman, Mohammad A. Hannan, Afsar Ahammed, ABM Kamrul-Hasan
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-11-01
Series:Indian Journal of Endocrinology and Metabolism
Subjects:
blood pressure
body weight
empagliflozin
hemoglobin a1c
hypoglycemia
type 2 diabetes
Online Access:https://journals.lww.com/10.4103/ijem.ijem_189_23
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://journals.lww.com/10.4103/ijem.ijem_189_23

Similar Items